Cardiac Implantable Electronic Device
Q&A: Dual-chamber leadless pacemaker successfully implanted in real-world practice
One of 2023’s most impactful FDA approvals in cardiology was for the world’s first dual-chamber leadless pacing system. In November, the technology was named one of Time magazine’s best inventions of the year.
FDA clears next-generation insertable device for long-term arrhythmia monitoring
Boston Scientific announced the FDA clearance and launch of its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke and syncope.
FDA clears insertable cardiac monitor with long battery life
Abbott announced the FDA cleared its insertable cardiac monitor for diagnosis and evaluation of irregular heartbeats.
AI update for insertable cardiac monitor nets FDA market clearance
Medtronic announced its artificial intelligence algorithm technology received market clearance from the FDA to apply the algorithms to its previous-generation insertable wireless cardiac monitor via cloud-based updates.
‘Car park clinic’ for cardiac device follow-up deemed successful model during pandemic
For patients with implanted cardiac devices, a “car park clinic” model successfully minimized contact with health care staff during the COVID-19 pandemic while also providing high patient satisfaction and reducing appointment times.
More antibiotics may not benefit high-risk patients undergoing cardiac device implantation
Antibiotic irrigation and oral antibiotics on top of chlorhexidine skin preparation, IV antibiotics and antibiotic envelope did not provide additional benefit for high-risk patients after cardiac device implantation, researchers reported.
Long-term insertable cardiac monitoring after ischemic stroke improves AF detection
Long-term insertable cardiac monitoring for atrial fibrillation among patients with ischemic stroke of atherosclerotic origin improved AF detection 10-fold compared with standard of care, a speaker reported.
Extravascular ICD safe, able to terminate ventricular arrhythmias
The novel extravascular implantable cardioverter defibrillator was implanted safely and was able to detect and terminate ventricular arrhythmias, according to a premarket study presented at the European Society of Cardiology Congress.
Non-fasting yields better well-being, safety in patients getting implantable device
Fasting up to 1 hour before a cardiac implantable electronic device procedure was more beneficial than fasting up to six hours before, in terms of well-being and safety, according to study results published in Europace.
FDA grants MR conditional labeling for implantable HF device
The FDA approved magnetic resonance conditional labeling for an implantable neurostimulator HF device, allowing patients with the device to safely undergo MRI, according to a press release from CVRx.